Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

NCT00598793 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart
DRUG: insulin glargine
DRUG: metformin
DRUG: pioglitazone

Sponsor

Novo Nordisk A/S